← Back to Cancer ScreeningFDA approved (CDx)
Foundation Medicine
Cancer patients seeking targeted therapy options
Variable
Test Performance
Sensitivity
N/A
Specificity
N/A
Detection Method
Genomic profiling
Turnaround
6-7 days median
Key Features
324-gene genomic panel • 324 genes • FDA-approved companion diagnostic • Treatment matching
Who It's For
Important Notes
Not for screening - analyzes existing tumors. Industry standard for tumor genomic profiling (324 genes). FoundationOne CDx (tissue, 7-day median) and FoundationOne Liquid CDx (blood, 6-day median) are both FDA approved. Broader portfolio includes FoundationOne Heme, RNA, Germline and PGx.
Learn more about Foundation Medicine
Discuss with your physician before ordering.
Visit Foundation MedicineCompare All